WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Son on target as South Korea beat Thailand 3China to launch Chang'eEvent launched to promote 'Highway 95' automotive tourism projectMarseille survive Villarreal fightback to go throughChina's benchmark interbank gold prices mixed MondayChina to ease tour restrictions for festivalCruise ship worker accused of stabbing 3 people with scissors on board vessel bound for AlaskaPillar homers twice as Sandoval and the Angels beat the Pirates 9Chinese cars gain popularity in BotswanaHong Kong, mainland self